Apelinergic system in endothelial cells and its role in angiogenesis in myocardial ischemia

Vascular Pharmacology

Volumn 76, Issue , 2015, Pages 1-10

  Novakov, Vera ^a   Sandhu, Gurpreet S ^b,c   Dragomir Daescu, Dan ^b,c   Klabusay, Martin ^d,e  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b MAYO CLINIC   (United States)

^c Mayo Clinic   (United States)

^d PALACKÝ UNIVERSITY   (Czech Republic)

^e MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Angiogenesis; Apelin; Endothelial cells; Myocardial infarction; Signalling pathways

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; ADENOSINE PHOSPHATE; ANGIOPOIETIN RECEPTOR; APELIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 9; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; HISTONE DEACETYLASE; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MYOCYTE ENHANCER FACTOR 2; OSTEOGENIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR HES 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; SIGNAL PEPTIDE;

ANGIOGENESIS; CAROTID ARTERY LIGATION; CELL DIFFERENTIATION; CELL JUNCTION; CELL PROLIFERATION; ENDOTHELIUM CELL; FEEDBACK SYSTEM; HALF LIFE TIME; HEART MUSCLE ISCHEMIA; HUMAN; HYPOXIA; NONHUMAN; PERICYTE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TREATMENT DURATION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; HEART INFARCTION; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY;

ANIMALS; ENDOTHELIAL CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; SIGNAL TRANSDUCTION;

EID: 84961144456     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.08.005     Document Type: Review

References (140)

1. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, N. Ferrara, Vascular endothelial growth factor is a secreted angiogenic molecule, Science 246 (4935) (1989) 1306-1309, http://dx.doi.org/10.1126/science.2479986.
2. S. Davis, T.H. Aldrich, P.F. Jones, A. Acheson, D.L. Compton, V. Jain, et al., Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning, Cell 87 (7) (1996) 1161-1169, http://dx.doi.org/10.1016/S0092-8674(00)81812-7.
3. R. Salcedo, K.Wasserman, H.A. Young, M.C. Grimm, O.M. Howard, M.R. Anver, et al., Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha, Am. J. Pathol. 154 (4) (1999) 1125-1135, http://dx.doi.org/10.1016/S0002-9440(10)65365-5.
4. H. Das, J.C. George, M. Joseph, M. Das, N. Abdulhameed, A. Blitz, et al., Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model, PLoS One 4 (10) (2009) e7325, http://dx.doi.org/10.1371/journal.pone.0007325.
5. S.W. Kim, D.W. Lee, L.H. Yu, H.Z. Zhang, C.E. Kim, J.M. Kim, et al., Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model, Cardiovasc. Res. 95 (4) (2012) 495-506, http://dx.doi.org/10.1093/cvr/cvs224.
6. M. Mathison, R.P. Gersch, A. Nasser, S. Lilo, M. Korman, M. Fourman, et al., In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor, J. Am. Heart Assoc. 1 (6) (2012) e005652, http://dx.doi.org/10.1161/JAHA.112.005652.
7. D. Ribatti, S. Baiguera, Phase II angiogenesis stimulators, Expert Opin. Investig. Drugs 22 (9) (2013) 1157-1166, http://dx.doi.org/10.1517/13543784.2013.813933.
8. Y. Shudo, J.E. Cohen, J.W. MacArthur, P. Atluri, P.F. Hsiao, E.C. Yang, et al., Spatially oriented, temporally sequential smooth muscle cell-endothelial progenitor cell bilevel cell sheet neovascularizes ischemic myocardium, Circulation 128 (11 Suppl. 1) (2013) S59-S68, http://dx.doi.org/10.1161/CIRCULATIONAHA.112.000293.
9. J.L. Carvalho, V.B. Braga, M.B. Melo, A.C. Campos, M.S. Oliveira, D.A. Gomes, et al., Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction, J. Cell. Mol. Med. 17 (5) (2013) 617-625, http://dx.doi.org/10.1111/jcmm.12036.
10. F. Lan, J. Liu, K.H. Narsinh, S. Hu, L. Han, A.S. Lee, et al., Safe genetic modification of cardiac stem cells using a site-specific integration technique, Circulation 126 (11 Suppl. 1) (2012) S20-S28, http://dx.doi.org/10.1161/CIRCULATIONAHA.111.084913.
11. H.H. Moon, M.K. Joo, H.Mok, M. Lee, K.C. Hwang, S.W. Kim, et al., MSC-based VEGF gene therapy in ratmyocardial infarctionmodel using facial amphipathic bile acidconjugated polyethyleneimine, Biomaterials 35 (5) (2014) 1744-1754, http://dx.doi.org/10.1016/j.biomaterials.2013.11.019.
12. F.R. Formiga, B. Pelacho, E. Garbayo, I. Imbuluzqueta, P. Díaz-Herráez, G. Abizanda, et al., Controlled delivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration, J. Control. Release 173 (2014) 132-139, http://dx.doi.org/10.1016/j.jconrel.2013.10.034.
13. X.Wang, Q. Li, Q. Hu, P. Suntharalingam, A.H.L. From, J. Zhang, Intra-myocardial injection of both growth factors and heart derived Sca-1+/CD31-cells attenuates post-MI LV remodeling more than does cell transplantation alone: neither intervention enhances functionally significant cardiomyocyte regeneration, PLoS One 9 (6) (2014) e95247, http://dx.doi.org/10.1371/journal.pone.0095247.
14. J.H. Distler, A. Hirth, M. Kurowska-Stolarska, R.E. Gay, S. Gay, O. Distler, Angiogenic and angiostatic factors in the molecular control of angiogenesis, Q. J. Nucl. Med. 47 (3) (2003) 149-161.
15. R.J. Lee, M.L. Springer, W.E. Blanco-Bose, R. Shaw, P.C. Ursell, H.M. Blau, VEGF gene delivery to myocardium: deleterious effects of unregulated expression, Circulation 102 (8) (2000) 898-901, http://dx.doi.org/10.1161/01.CIR.102.8.898.
16. Y. Ito, H. Tsurushima, M. Sato, A. Ito, A. Oyane, Y. Sogo, et al., Angiogenesis therapy for brain infarction using a slow-releasing drug delivery system for fibroblast growth factor 2, Biochem. Biophys. Res. Commun. 432 (1) (2013) 182-187, http://dx.doi.org/10.1016/j.bbrc.2013.01.013.
17. X. Yang, W. Zhu, P. Zhang, K. Chen, L. Zhao, J. Li, et al., Apelin-13 stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in myocardial microvascular endothelial cells, Mol. Med. Rep. 9 (5) (2014) 1590-1596, http://dx.doi.org/10.3892/mmr.2014.1984.
18. H. Kidoya, H. Naito, N. Takakura, Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia, Blood 115 (15) (2010) 3166-3174, http://dx.doi.org/10.1182/blood-2009-07-232306.
19. A. Kasai, Y. Ishimaru, K. Higashino, K. Kobayashi, A. Yamamuro, Y. Yoshioka, et al., Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis, Angiogenesis 16 (3) (2013) 723-724, http://dx.doi.org/10.1007/s10456-013-9349-6.
20. W. Wang, S.M. McKinnie, V.B. Patel, G. Haddad, Z. Wang, P. Zhabyeyev, et al., Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues, J. Am. Heart. Assoc. 2 (4) (2013) e000249, http://dx.doi.org/10.1161/JAHA.113.000249.
21. H. Zeng, X. He, X. Hou, L. Li, J.X. Chen, Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3, Am. J. Physiol. Heart Circ. Physiol. 306 (4) (2014) H585-H597, http://dx.doi.org/10.1152/ajpheart.00821.2013.
22. K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, M.X. Zou, et al., Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor, Biochem. Biophys. Res. Commun. 251 (2) (1998) 471-476, http://dx.doi.org/10.1006/bbrc.1998.9489.
23. I. Falcão-Pires, A.F. Leite-Moreira, Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target, Rev. Port. Cardiol. 24 (10) (2005) 1263-1276.
24. B. Masri, B. Knibiehler, Y. Audigier, Apelin signalling: a promising pathway from cloning to pharmacology, Cell. Signal. 17 (4) (2005) 415-426, http://dx.doi.org/10.1016/j.cellsig.2004.09.018.
25. D.K. Lee, S.S. Ferguson, S.R. George, B.F. O'Dowd, The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with β-arrestin, Biochem. Biophys. Res. Commun. 395 (2) (2010) 185-189, http://dx.doi.org/10.1016/j.bbrc.2010.03.151.
26. Y. Kawamata, Y. Habata, S. Fukusumi, M. Hosoya, R. Fujii, S. Hinuma, et al., Molecular properties of apelin: tissue distribution and receptor binding, Biochim. Biophys. Acta 1538 (2-3) (2001) 162-171, http://dx.doi.org/10.1016/S0167-4889(00)00143-9.
27. N. De Mota, A. Reaux-Le Goazigo, S. El Messari, N. Chartrel, D. Roesch, C. Dujardin, et al., Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release, Proc. Natl. Acad. Sci. U. S. A. 101 (28) (2004) 10464-10469, http://dx.doi.org/10.1073/pnas.0403518101.
28. M. Azizi, X. Iturrioz, A. Blanchard, S. Peyrard, N. De Mota, N. Chartrel, et al., Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli, J. Am. Soc. Nephrol. 19 (5) (2008) 1015-1024, http://dx.doi.org/10.1681/ASN.2007070816.
29. J.J. Maguire, M.J. Kleinz, S.L. Pitkin, A.P. Davenport, [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease, Hypertension 54 (3) (2009) 598-604, http://dx.doi.org/10.1161/HYPERTENSIONAHA.
30. A.M. O'Carroll, T.L. Selby, M. Palkovits, S.J. Lolait, Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues, Biochim. Biophys. Acta 1492 (1) (2000) 72-80, http://dx.doi.org/10.1016/S0167-4781(00)00072-5.
31. M.J. Kleinz, J.N. Skepper, A.P. Davenport, Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smoothmuscle and endothelial cells, Regul. Pept. 126 (3) (2005) 233-240, http://dx.doi.org/10.1016/j.regpep.2004.10.019.
32. C.G. Kostopoulos, S.G. Spiroglou, J.N. Varakis, E. Apostolakis, H.H. Papadaki, Adiponectin/T-cadherin and apelin/APJ expression in human arteries and periadventitial fat: implication of local adipokine signaling in atherosclerosis? Cardiovasc. Pathol. 23 (3) (2014) 131-138, http://dx.doi.org/10.1016/j.carpath.2014.02.003.
33. G.E. Davis, D.R. Senger, Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization, Circ. Res. 97 (11) (2005) 1093-1107, http://dx.doi.org/10.1161/01.RES.0000191547.64391.e3.
34. H. Gerhardt, M. Golding, M. Fruttiger, C. Ruhrberg, A. Lundkvist, A. Abramsson, et al., VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia, J. Cell Biol. 161 (6) (2003) 1163-1177, http://dx.doi.org/10.1083/jcb.200302047.
35. R. del Toro, C. Prahst, T.Mathivet, G. Siegfried, J.S. Kaminker, B. Larrivee, et al., Identification and functional analysis of endothelial tip cell-enriched genes, Blood 116 (19) (2010) 4025-4033, http://dx.doi.org/10.1182/blood-2010-02-270819.
36. H. Kidoya, M. Ueno, Y. Yamada, N. Mochizuki, M. Nakata, T. Yano, et al., Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis, EMBO J. 27 (3) (2008) 522-534, http://dx.doi.org/10.1038/sj.emboj.7601982.
37. H. Kidoya, N. Kunii, H. Naito, F. Muramatsu, Y. Okamoto, T. Nakayama, et al., The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy, Oncogene 31 (27) (2012) 3254-3264, http://dx.doi.org/10.1038/onc.2011.489.
38. H. Kawahara, H. Naito, K. Takara, T. Wakabayashi, H. Kidoya, N. Takakura, Tumor endothelial cell-specific drug delivery system using apelin-conjugated liposomes, PLoS One 8 (6) (2013) e65499, http://dx.doi.org/10.1371/journal.pone.0065499.
39. P. Lindahl, B.R. Johansson, P. Levéen, C. Betsholtz, Pericyte loss and microaneurysm formation in PDGF-B-deficient mice, Science 277 (5323) (1997) 242-245, http://dx.doi.org/10.1126/science.277.5323.242.
40. T.N. Sato, Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, et al., Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation, Nature 376 (6535) (1995) 70-74, http://dx.doi.org/10.1038/376070a0.
41. H.G. Augustin, G.Y. Koh, G. Thurston, K. Alitalo, Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system, Nat. Rev. Mol. Cell Biol. 10 (3) (2009) 165-177, http://dx.doi.org/10.1038/nrm2639.
42. R.E. Kälin, M.P. Kretz, A.M. Meyer, A. Kispert, F.L. Heppner, A.W. Brändli, Paracrine and autocrinemechanisms of apelin signaling govern embryonic and tumor angiogenesis, Dev. Biol. 305 (2) (2007) 599-614, http://dx.doi.org/10.1016/j.ydbio.2007.03.004.
43. R. Rastaldo, S. Cappello, A. Folino, G.N. Berta, A.E. Sprio, G. Losano, et al., Apelin-13 limits infarct size and improves cardiac postischemic mechanical recovery only if given after ischemia: tissue distribution and receptor binding, Am. J. Physiol. Heart Circ. Physiol. 300 (6) (2011) H2308-H2315, http://dx.doi.org/10.1152/ajpheart.01177.2010.
44. Y. Kang, J. Kim, J.P. Anderson, J.Wu, S.R. Gleim, R.K. Kundu, et al., Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development, Circ. Res. 113 (1) (2013) 22-31, http://dx.doi.org/10.1161/CIRCRESAHA.
45. A. Kasai, Y. Ishimaru, T. Kinjo, T. Satooka, N.Matsumoto, Y. Yoshioka, et al., Apelin is a crucial factor for hypoxia-induced retinal angiogenesis, Arterioscler. Thromb. Vasc. Biol. 30 (11) (2010) 2182-2187, http://dx.doi.org/10.1161/ATVBAHA.110.209775.
46. G.L. Semenza, M.K. Nejfelt, S.M. Chi, S.E. Antonarakis, Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene, Proc. Natl. Acad. Sci. U. S. A. 88 (13) (1991) 5680-5684.
47. C.M. Cox, S.L. D'Agostino, M.K.Miller, R.L. Heimark, P.A. Krieg, Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo, Dev. Biol. 296 (1) (2006) 177-189, http://dx.doi.org/10.1016/j.ydbio.2006.04.452.
48. V.P. Ronkainen, J.J. Ronkainen, S.L. Hänninen, H. Leskinen, J.L. Ruas, T. Pereira, et al., Hypoxia inducible factor regulates the cardiac expression and secretion of apelin, FASEB J. 21 (8) (2007) 1821-1830, http://dx.doi.org/10.1096/fj.06-7294com.
49. M. Eyries, G. Siegfried, M. Ciumas, K. Montagne, M. Agrapart, F. Lebrin, et al., Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis, Circ. Res. 103 (4) (2008) 432-440, http://dx.doi.org/10.1161/CIRCRESAHA.108.179333.
50. D. Liu, J. Wang, B. Kinzel, M. Mueller, X. Mao, R. Valdez, et al., Dosage-dependent requirement of BMP type II receptor for maintenance of vascular integrity, Blood 110 (5) (2007) 1502-1510, http://dx.doi.org/10.1182/blood-2006-11-058594.
51. L. David, C. Mallet, M. Keramidas, N. Lamandé, J.M. Gasc, S. Dupuis-Girod, et al., Bone morphogenetic protein-9 is a circulating vascular quiescence factor, Circ. Res. 102 (8) (2008) 914-922, http://dx.doi.org/10.1161/CIRCRESAHA.107.165530.
52. O. Poirier, M. Ciumas, M. Eyries, K. Montagne, S. Nadaud, F. Soubrier, Inhibition of apelin expression by BMP signaling in endothelial cells, Am. J. Physiol. Cell Physiol. 303 (11) (2012) C1139-C1145, http://dx.doi.org/10.1152/ajpcell.00168.2012.
53. N. Ricard, D. Ciais, S. Levet, M. Subileau, C. Mallet, T.A. Zimmers, et al., BMP9 and BMP10 are critical for postnatal retinal vascular remodeling, Blood 119 (25) (2012) 6162-6171, http://dx.doi.org/10.1182/blood-2012-01-407593.
54. B. Larrivée, C. Prahst, E. Gordon, R. del Toro, T. Mathivet, A. Duarte, et al., ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway, Dev. Cell 22 (3) (2012) 489-500, http://dx.doi.org/10.1016/j.devcel.2012.02.005.
55. T.P. Alastalo, M. Li, V. de Jesus Perez, D. Pham, H. Sawada, J.K.Wang, et al., Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival, J. Clin. Invest. 121 (9) (2011) 3735-3746, http://dx.doi.org/10.1172/JCI43382.
56. V.A. de Jesus Perez, T.P. Alastalo, J.C. Wu, J.D. Axelrod, J.P. Cooke, M. Amieva, et al., Bonemorphogenetic protein 2 induces pulmonary angiogenesis viaWnt-β-catenin andWnt-RhoA-Rac1 pathways, J. Cell Biol. 184 (1) (2009) 83-99, http://dx.doi.org/10.1083/jcb.200806049.
57. M. Moser, O. Binder, Y. Wu, J. Aitsebaomo, R. Ren, C. Bode, et al., BMPER, a novel endothelial cell precursor-derived protein, antagonizes bone morphogenetic protein signaling and endothelial cell differentiation, Mol. Cell. Biol. 23 (16) (2003) 5664-5679, http://dx.doi.org/10.1128/MCB.23.16.5664-5679.2003.
58. J. Heinke, M. Juschkat, A. Charlet, L. Mnich, T. Helbing, C. Bode, et al., Antagonism and synergy between extracellular BMP modulators Tsg and BMPER balance blood vessel formation, J. Cell Sci. 126 (14) (2013) 3082-3094, http://dx.doi.org/10.1242/jcs.122333.
59. P. Saharinen, L. Eklund, J.Miettinen, R.Wirkkala, A. Anisimov, M.Winderlich, et al., Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts, Nat. Cell Biol. 10 (5) (2008) 527-537, http://dx.doi.org/10.1038/ncb1715.
60. D. Qin, T. Trenkwalder, S. Lee, O. Chillo, E. Deindl, C. Kupatt, et al., Early vessel destabilization mediated by angiopoietin-2 and subsequent vessel maturation via angiopoietin-1 induce functional neovasculature after ischemia, PLoS One 8 (4) (2013) e61831, http://dx.doi.org/10.1371/journal.pone.0061831.
61. M. Scharpfenecker, U. Fiedler, Y. Reiss, H.G. Augustin, The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism, J. Cell Sci. 118 (4) (2005) 771-780, http://dx.doi.org/10.1242/jcs.01653.
62. N. Takakura, H. Kidoya, Maturation of blood vessels by haematopoietic stem cells and progenitor cells: involvement of apelin/APJ and angiopoietin/Tie2 interactions in vessel caliber size regulation, Thromb. Haemost. 101 (6) (2009) 999-1005, http://dx.doi.org/10.1160/TH08-06-0358.
63. S.D. Cushing, J.A. Berliner, J.A. Valente, M.C. Territo, M. Navab, F. Parhami, et al., Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells, Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 5134-5138.
64. N.I. Moldovan, P.J. Goldschmidt-Clermont, J. Parker-Thornburg, S.D. Shapiro, P.E. Kolattukudy, Contribution ofmonocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemicmyocardium, Circ. Res. 87 (5) (2000) 378-384, http://dx.doi.org/10.1161/01.RES.87.5.378.
65. K.H. Hong, J. Ryu, K.H. Han, Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A, Blood 105 (4) (2005) 1405-1407, http://dx.doi.org/10.1182/blood-2004-08-3178.
66. E. Caselli, S. Fiorentini, C. Amici, D. Di Luca, A. Caruso, M.G. Santoro, Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF-κB pathway, Blood 109 (7) (2007) 2718-2726, http://dx.doi.org/10.1182/blood-2006-03-012500.
67. J. Ma, Q.Wang, T. Fei, J.D.J. Han, Y.G. Chen, MCP-1 mediates TGF-β-induced angiogenesis by stimulating vascular smooth muscle cell migration, Blood 109 (3) (2007) 987-994, http://dx.doi.org/10.1182/blood-2006-07-036400.
68. A.C. Aplin, M. Gelati, E. Fogel, E. Carnevale, R.F. Nicosia, Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis, Physiol. Genomics 27 (1) (2006) 20-28, http://dx.doi.org/10.1152/physiolgenomics.00048.2006.
69. N.J. Leeper, M.M. Tedesco, Y. Kojima, G.M. Schultz, R.K. Kundu, E.A. Ashley, et al., Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation, Am. J. Physiol. Heart Circ. Physiol. 296 (5) (2009) H1329-H1335, http://dx.doi.org/10.1152/ajpheart.01341.2008.
70. C. Hara, A. Kasai, F. Gomi, T. Satooka, S. Sakimoto, K. Nakai, et al., Laser-induced choroidal neovascularization in mice attenuated by deficiency in the apelin-APJ system, Invest. Ophthalmol. Vis. Sci. 54 (6) (2013) 4321-4329, http://dx.doi.org/10.1167/iovs.13-11611.
71. Y. Lu, X. Zhu, G.X. Liang, R.R. Cui, Y. Liu, S.S.Wu, et al., Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells, Amino Acids 43 (5) (2012) 2125-3136, http://dx.doi.org/10.1007/s00726-012-1298-7.
72. J.H. Lee, H. Kim, J.H. Woo, E.H. Joe, I. Jou, 5, 8, 11, 14 eicosatetraynoic acid suppresses CCL2/MCP-1 expression in IFN-γ-stimulated astrocytes by increasing MAPK phosphatase-1 mRNA stability, J. Neuroinflammation 9 (2012) 34, http://dx.doi.org/10.1186/1742-2094-9-34.
73. W.G. Sanders, C. Morisseau, B.D. Hammock, A.K. Cheung, C.M. Terry, Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and antiinflammatory effects of a soluble epoxide hydrolase inhibitor, Am. J. Physiol. Cell Physiol. 303 (3) (2012) C278-C290, http://dx.doi.org/10.1152/ajpcell.00386.2011.
74. M. Siragusa, R. Katare, M. Meloni, F. Damilano, E. Hirsch, C. Emanueli, et al., Involvement of phosphoinositide 3-kinase γ in angiogenesis and healing of experimental myocardial infarction inmice, Circ. Res. 106 (4) (2010) 757-768, http://dx.doi.org/10.1161/CIRCRESAHA.109.207449.
75. Y. Tang, C. Vater, A. Jacobi, C. Liebers, X. Zou, M. Stiehler, Salidroside exerts angiogenic and cytoprotective effects on human bone marrow-derived endothelial progenitor cells via Akt/mTOR/p70S6K and MAPK signalling pathways, Br. J. Pharmacol. 171 (9) (2014) 2440-2456, http://dx.doi.org/10.1111/bph.12611.
76. B. Masri, N. Morin, M. Cornu, B. Knibiehler, Y. Audigier, Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells, FASEB J. 18 (15) (2004) 1909-1911, http://dx.doi.org/10.1096/fj.04-1930fje.
77. J. Berta, M.A. Hoda, V. Laszlo, A. Rozsas, T. Garay, S. Torok, et al., Apelin promotes lymphangiogenesis and lymph node metastasis, Oncotarget 5 (12) (2014) 4426-4437.
78. F. Vinals, J.C. Chambard, J. Pouyssegur, p70 S6 kinase-mediated protein synthesis is a critical step for vascular endothelial cell proliferation, J. Biol. Chem. 274 (38) (1999) 26776-26782, http://dx.doi.org/10.1074/jbc.274.38.26776.
79. D.H. Cho, Y.J. Choi, S.A. Jo, J. Ryou, J.Y. Kim, J. Chung, et al., Troglitazone acutely inhibits protein synthesis in endothelial cells via a novel mechanism involving protein phosphatase 2A-dependent p70 S6 kinase inhibition, Am. J. Physiol. Cell Physiol. 291 (2) (2006) C317-C326, http://dx.doi.org/10.1152/ajpcell.00491.2005.
80. L.Z. Liu, J.Z. Zheng, X.R. Wang, B.H. Jiang, Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis, Cancer Res. 68 (19) (2008) 8183-8188, http://dx.doi.org/10.1158/0008-5472.CAN-08-0819.
81. K.I. Mitchelhill, B.J. Michell, C.M. House, D. Stapleton, J. Dyck, J. Gamble, et al., Posttranslational modifications of the 5'-AMP-activated protein kinase β1 subunit, J. Biol. Chem. 272 (39) (1997) 24475-24479, http://dx.doi.org/10.1074/jbc.272.39.24475.
82. D. Nagata, M. Mogi, K. Walsh, AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress, J. Biol. Chem. 278 (33) (2003) 31000-31006, http://dx.doi.org/10.1074/jbc.M300643200.
83. N. Ouchi, H. Kobayashi, S. Kihara, M. Kumada, K. Sato, T. Inoue, et al., Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signalling in endothelial cells, J. Biol. Chem. 279 (2) (2004) 1304-1309, http://dx.doi.org/10.1074/jbc.M310389200.
84. C. Attané, D. Daviaud, C. Dray, R. Dusaulcy, M. Masseboeuf, D. Prévot, et al., Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo, J.Mol. Endocrinol. 46 (1) (2011) 21-28, http://dx.doi.org/10.1677/JME-10-0105.
85. S. Xu, P. Han, M. Huang, J.C. Wu, C. Chang, P.S. Tsao, et al., In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake, Peptides 37 (2) (2012) 320-326, http://dx.doi.org/10.1016/j.peptides.2012.08.004.
86. M. Philippova, M.B. Joshi, D. Pfaff, E. Kyriakakis, K. Maslova, P. Erne, et al., Tcadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells, Cardiovasc. Res. 93 (3) (2012) 498-507, http://dx.doi.org/10.1093/cvr/cvs004.
87. J. Krupinski, M. Abudawood, S. Matou-Nasri, R. Al-Baradie, E.B. Petcu, C. Justicia, et al., Citicoline induces angiogenesis improving survival of vascular/human brainmicrovessel endothelial cells through pathways involving ERK1/2 and insulin receptor substrate-1, Vasc. Cell 4 (1) (2012) 20, http://dx.doi.org/10.1186/2045-824X-4-20.
88. G. Liu, J. Han, J. Profirovic, E. Strekalova, T.A. Voyno-Yasenetskaya, Ga13 regulates MEF2-dependent gene transcription in endothelial cells: role in angiogenesis, Angiogenesis 12 (1) (2009) 1-15, http://dx.doi.org/10.1007/s10456-008-9123-3.
89. C. Sturtzel, J. Testori, B. Schweighofer, M. Bilban, E. Hofer, The transcription factor MEF2C negatively controls angiogenic sprouting of endothelial cells depending on oxygen, PLoS One 9 (7) (2014) e101521, http://dx.doi.org/10.1371/journal.pone.0101521.
90. T.A. McKinsey, C.L. Zhang, E.N. Olson, Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5, Proc. Natl. Acad. Sci. U. S. A. 97 (26) (2000) 14400-14405, http://dx.doi.org/10.1073/pnas.260501497.
91. R.J. Dekker, R.A. Boon, M.G. Rondaij, A. Kragt, O.L. Volger, Y.W. Elderkamp, et al., KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium, Blood 107 (11) (2006) 4354-4363, http://dx.doi.org/10.1182/blood-2005-08-3465.
92. Y. Song, X. Li, D. Wang, C. Fu, Z. Zhu, M.H. Zou, et al., Transcription factor Krüppellike factor 2 plays a vital role in endothelial colony forming cells differentiation, Cardiovasc. Res. 99 (3) (2013) 514-524, http://dx.doi.org/10.1093/cvr/cvt113.
93. Z. Lin, V. Natesan, H. Shi, F. Dong, D. Kawanami, G.H. Mahabeleshwar, et al., Krüppellike factor 2 regulates endothelial barrier function, Arterioscler. Thromb. Vasc. Biol. 30 (10) (2010) 1952-1959, http://dx.doi.org/10.1161/ATVBAHA.110.211474.
94. S.M. Chandra, H. Razavi, J. Kim, R. Agrawal, R.K. Kundu, V. de Jesus Perez, et al., Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension, Arterioscler. Thromb. Vasc. Biol. 31 (4) (2011) 814-820, http://dx.doi.org/10.1161/ATVBAHA.110.219980.
95. D.L.McLean, J. Kim, Y. Kang, H. Shi, G.B. Atkins, M.K. Jain, et al., Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells-brief report, Arterioscler. Thromb. Vasc. Biol. 32 (11) (2012) 2640-2643, http://dx.doi.org/10.1161/ATVBAHA.
96. I.S. Kwon, W. Wang, S. Xu, Z.G. Jin, Histone deacetylase 5 interacts with Krüppellike factor 2 and inhibits its transcriptional activity in endothelium, Cardiovasc. Res. 104 (1) (2014) 127-137, http://dx.doi.org/10.1093/cvr/cvu183.
97. W. Wang, C.H. Ha, B.S. Jhun, C. Wong, M.K. Jain, Z.G. Jin, Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS, Blood 115 (14) (2010) 2971-2979, http://dx.doi.org/10.1182/blood-2009-05-224824.
98. T. Hashimoto, M. Kihara, J. Ishida, N. Imai, S. Yoshida, Y. Toya, et al., Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells, Arterioscler. Thromb. Vasc. Biol. 26 (6) (2006) 1267-1272, http://dx.doi.org/10.1161/01.ATV.0000218841.39828.91.
99. A.D. Hofmann, F. Friedmacher, H. Takahashi, M. Hunziker, J.H. Gosemann, P. Puri, Decreased apelin and apelin-receptor expression in the pulmonary vasculature of nitrofen-induced congenital diaphragmatic hernia, Pediatr. Surg. Int. 30 (2) (2014) 197-203, http://dx.doi.org/10.1007/s00383-013-3450-1.
100. L. Li, L. Li, F. Xie, Z. Zhang, Y. Guo, G. Tang, et al., Jagged-1/Notch3 signaling transduction pathway is involved in apelin-13-induced vascular smooth muscle cells proliferation, Acta Biochim. Biophys. Sin. (Shanghai) 45 (10) (2013) 875-881, http://dx.doi.org/10.1093/abbs/gmt085.
101. Q.F. Liu, H.W. Yu, L. You, M.X. Liu, K.Y. Li, G.Z. Tao, Apelin-13-induced proliferation and migration induced of rat vascular smooth muscle cells is mediated by the upregulation of Egr-1, Biochem. Biophys. Res. Commun. 439 (2) (2013) 235-240, http://dx.doi.org/10.1016/j.bbrc.2013.08.051.
102. Y. Kojima, R.K. Kundu, C.M. Cox, N.J. Leeper, J.A. Anderson, H.J. Chun, et al., Upregulation of the apelin-APJ pathway promotes neointima formation in the carotid ligation model in mouse, Cardiovasc. Res. 87 (1) (2010) 156-165, http://dx.doi.org/10.1093/cvr/cvq052.
103. M. Heil, T. Ziegelhoeffer, F. Pipp, S. Kostin, S. Martin, M. Clauss, et al., Blood monocyte concentration is critical for enhancement of collateral artery growth, Am. J. Physiol. Heart Circ. Physiol. 283 (6) (2002) H2411-H2419, http://dx.doi.org/10.1152/ajpheart.01098.2001.
104. F.S. Czepluch, M. Bernhardt, H. Kuschicke, R. Gogiraju, M.R. Schroeter, J. Riggert, et al., In vitro and in vivo effects of human monocytes and their subsets on new vessel formation, Microcirculation 21 (2) (2014) 148-158, http://dx.doi.org/10.1111/micc.12100.
105. Y. Okuno, A. Nakamura-Ishizu, K. Kishi, T. Suda, Y. Kubota, Bone marrow-derived cells serve as proangiogenic macrophages but not endothelial cells in wound healing, Blood 117 (19) (2011) 5264-5272, http://dx.doi.org/10.1182/blood-2011-01-330720.
106. B. Passlick, D. Flieger, H.W. Ziegler-Heitbrock, Identification and characterization of a novel monocyte subpopulation in human peripheral blood, Blood 74 (7) (1989) 2527-2534.
107. G. Draude, P. von Hundelshausen, M. Frankenberger, H.W. Ziegler-Heitbrock, C. Weber, Distinct scavenger receptor expression and function in the human CD14(+)/CD16(+) monocyte subset, Am. J. Physiol. 276 (4) (1999) H1144-H1149.
108. M. Nahrendorf, M.J. Pittet, F.K. Swirski, Monocytes: protagonists of infarct inflammation and repair after myocardial infarction, Circulation 121 (22) (2010) 2437-2445, http://dx.doi.org/10.1161/CIRCULATIONAHA.109.916346.
109. W. Choe, A. Albright, J. Sulcove, S. Jaffer, J. Hesselgesser, E. Lavi, et al., Functional expression of the seven-transmembrane HIV-1 co-receptor APJ in neural cells, J. Neurovirol. 6 (Suppl. 1) (2000) S61-S69.
110. S. Obara, S. Akifusa, W. Ariyoshi, T. Okinaga, M. Usui, K. Nakashima, et al., Pyroglutamated apelin-13 inhibits lipopolysaccharide-induced production of pro-inflammatory cytokines in murine macrophage J774.1 cells, Mod. Res. Inflamm. 3 (2) (2014) 59-66, http://dx.doi.org/10.4236/mri.2014.32007.
111. R.T. Day, R.C. Cavaglieri, D. Feliers, Apelin retards the progression of diabetic nephropathy, Am. J. Physiol. Renal Physiol. 304 (6) (2013) F788-F800, http://dx.doi.org/10.1152/ajprenal.00306.2012.
112. X. Li, X. Zhang, F. Li, L. Chen, L. Li, X. Qin, et al., 14-3-3 mediates apelin-13-induced enhancement of adhesion of monocytes to human umbilical vein endothelial cells, Acta Biochim. Biophys. Sin. (Shanghai) 42 (6) (2010) 403-409.
113. C.S. Pan, X. Teng, J. Zhang, Y. Cai, J. Zhao, W.Wu, et al., Apelin antagonizes myocardial impairment in sepsis, J. Card. Fail. 16 (7) (2010) 609-617, http://dx.doi.org/10.1016/j.cardfail.2010.02.002.
114. P. Grzywocz, K. Mizia-Stec, M. Wybraniec, J. Chudek, Adipokines and endothelial dysfunction in acute myocardial infarction and the risk of recurrent cardiovascular events, J. Cardiovasc. Med. (Hagerstown) 16 (1) (2015) 37-44, http://dx.doi.org/10.2459/JCM.0000000000000042.
115. R.A.Weir, K.S. Chong, J.R. Dalzell, C.J. Petrie, C.A.Murphy, T. Steedman, et al., Plasma apelin concentration is depressed following acute myocardial infarction in man, Eur. J. Heart Fail. 11 (6) (2009) 551-558, http://dx.doi.org/10.1093/eurjhf/hfp043.
116. Y. Azizi, M. Faghihi, A. Imani, M. Roghani, A. Nazari, Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction, Peptides 46 (2013) 76-82, http://dx.doi.org/10.1016/j.peptides.2013.05.006.
117. L. Li, H. Zeng, J.X. Chen, Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction, Am. J. Physiol. Heart Circ. Physiol. 303 (5) (2012) H605-H618, http://dx.doi.org/10.1152/ajpheart.00366.2012.
118. Y. Azizi, M. Faghini, A. Imani, M. Roghani, A. Zekri, M.B. Mobasheri, et al., Postinfarct treatment with [Pyr1]apelin-13 improvesmyocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats, Eur. J. Pharmacol. 761 (2015) 101-108, http://dx.doi.org/10.1016/j.ejphar.2015.04.034.
119. C.J. Charles, M.T. Rademaker, A.M. Richards, Apelin-13 induces a biphasic haemodynamic response and hormonal activation in normal conscious sheep, J. Endocrinol. 189 (3) (2006) 701-710.
120. M. Wang, R.C. Gupta, S. Rastogi, S. Kohli, M.S. Sabbah, K. Zhang, et al., Effects of acute intravenous infusion of apelin on left ventricular function in dogs with advanced heart failure, J. Card. Fail. 19 (7) (2013) 509-516, http://dx.doi.org/10.1016/j.cardfail.2013.05.004.
121. V. Serpooshan, S. Sivanesan, X. Huang, M. Mahmoudi, A.V. Malkovskiy, M. Zhao, et al., [Pyr1]-Apelin-13 delivery via nano-liposomal encapsulation attenuates pressure overload-induced cardiac dysfunction, Biomaterials 37 (2015) 289-298, http://dx.doi.org/10.1016/j.biomaterials.2014.08.045.
122. J. Gavard, J.S. Gutkind, VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin, Nat. Cell Biol. 8 (11) (2006) 1223-1234, http://dx.doi.org/10.1038/ncb1486.
123. A.G. Japp, N.L. Cruden, G. Barnes, N. van Gemeren, J. Mathews, J. Adamson, et al., Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure, Circulation 121 (16) (2010) 1818-1827, http://dx.doi.org/10.1161/CIRCULATIONAHA.109.911339.
124. C. Vickers, P. Hales, V. Kaushik, L. Dick, J. Gavin, J. Tang, et al., Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase, J. Biol. Chem. 277 (17) (2002) 14838-14843.
125. A.L. Brame, J.J.Maguire, P. Yang, A. Dyson, R. Torella, J. Cheriyan, et al., Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist, Hypertension 65 (4) (2015) 834-840, http://dx.doi.org/10.1161/HYPERTENSIONAHA.114.05099.
126. A. Murza, A. Parent, E. Besserer-Offroy, H. Tremblay, F. Karadereye, N. Beaudet, et al., Elucidation of the structure-activity relationships of apelin: influence of unnatural amino acids on binding, signaling, and plasma stability, ChemMedChem 7 (2) (2012) 318-325, http://dx.doi.org/10.1002/cmdc.201100492.
127. J. Hamada, J. Kimura, J. Ishida, T. Kohda, S.Morishita, S. Ichihara, et al., Evaluation of novel cyclic analogues of apelin, Int. J. Mol. Med. 22 (4) (2008) 547-552.
128. O.I. Pisarenko, L.I. Serebryakova, I.M. Studneva, Y.A. Pelogeykina, O.V. Tskitishvili, Z.D. Bespalova, et al., Effects of structural analogues of apelin-12 in acute myocardial infarction in rats, J. Pharmacol. Pharmacother. 4 (3) (2013) 198-203, http://dx.doi.org/10.4103/0976-500X.114600.
129. E. Ceraudo, C. Galanth, E. Carpentier, I. Banegas-Font, A.M. Schonegge, R. Alvear-Perez, et al., Biased signaling favoring gi over β-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine, J. Biol. Chem. 289 (35) (2014) 24599-24610, http://dx.doi.org/10.1074/jbc.M113.541698.
130. N. Pavo, S. Charwat, N. Nyolczas, A. Jakab, Z. Murlasits, J. Bergler-Klein, et al., Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences, J. Mol. Cell. Cardiol. 75 (2014) 12-24, http://dx.doi.org/10.1016/j.yjmcc.2014.06.016.
131. S. Alshammary, S. Fukushima, S.Miyagawa, T.Matsuda, H. Nishi, A. Saito, et al., Impact of cardiac stem cell sheet transplantation on myocardial infarction, Surg. Today 43 (9) (2013) 970-976, http://dx.doi.org/10.1007/s00595-013-0528-2.
132. N. Tano, T. Narita, M. Kaneko, C. Ikebe, S.R. Coppen, N.G. Campbell, et al., Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study, Mol. Ther. 22 (10) (2014) 1864-1871, http://dx.doi.org/10.1038/mt.2014.110.
133. S.G. Ong, W.H. Lee, M. Huang, D. Dey, K. Kodo, V. Sanchez-Freire, et al., Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer, Circulation 130 (11 Suppl. 1) (2014) S60-S69, http://dx.doi.org/10.1161/CIRCULATIONAHA.113.007917.
134. L. Li, H. Zeng, X. Hou, X. He, J.X. Chen, Myocardial injection of apelinoverexpressing bone marrow cells improves cardiac repair via upregulation of Sirt3 after myocardial infarction, PLoS One 8 (9) (2013) e71041, http://dx.doi.org/10.1371/journal.pone.0071041.
135. A.G. Japp, N.L. Cruden, D.A. Amer, V.K. Li, E.B. Goudie, N.R. Johnston, et al., Vascular effects of apelin in vivo inman, J. Am. Coll. Cardiol. 52 (11) (2008) 908-913, http://dx.doi.org/10.1016/j.jacc.2008.06.013.
136. E. Van Coillie, P. Proost, I. Van Aelst, S. Struyf, M. Polfliet, I. De Meester, et al., Functional comparison of two humanmonocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV, Biochemistry 37 (36) (1998) 12672-12680.
137. Y. Dor, V. Djonov, R. Abramovitch, A. Itin, G.I. Fishman, P. Carmeliet, et al., Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy, EMBO J. 21 (8) (2002) 1939-1947.
138. H.K. Makadia, S.J. Siegel, Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier, Polymers (Basel) 3 (3) (2011) 1377-1397, http://dx.doi.org/10.3390/polym3031377.
139. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton, V. Préat, PLGA-based nanoparticles: an overview of biomedical applications, J. Control. Release 161 (2) (2012) 505-522, http://dx.doi.org/10.1016/j.jconrel.2012.01.043.
140. E.A. Ashley, J. Powers, M. Chen, R. Kundu, T. Finsterbach, A. Caffarelli, et al., The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo, Cardiovasc. Res. 65 (1) (2005) 73-82, http://dx.doi.org/10.1016/j.cardiores.2004.08.018.